Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Medical Chemistry,
Faculty of Medicine,
Doctoral School of Molecular Medicine,
Department of Medical Chemistry, Faculty of Medicine
Eliza Guti has not added Biography.
If you are Eliza Guti and would like to personalize this page please email our Author Liaison for assistance.
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
Cancer immunology, immunotherapy : CII Sep, 2022 | Pubmed ID: 35066605
University of Debrecen
Eliza Guti*,1,2,
Ákos Máté Bede*,1,3,
Csongor Váróczy*,1,3,
Csaba Hegedűs1,
Máté Á. Demény1,4,
László Virág1,4
1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen,
2Doctoral School of Molecular Medicine, University of Debrecen,
3National Academy of Scientist Education, University of Debrecen,
4, ELKH-DE Cell Biology and Signaling Research Group
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved